Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Acumen Pharmaceuticals, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2023 |
4
| Stalfort John A III (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $5.2, valued at
$130k
|
|
| 06/07/2023 |
4
| Stoppel Laura (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $5.2, valued at
$130k
|
|
| 06/07/2023 |
4
| Porter Derrell (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $5.2, valued at
$130k
|
|
| 06/07/2023 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $5.2, valued at
$130k
|
|
| 06/07/2023 |
4
| Fountain Nathan B (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $5.2, valued at
$130k
|
|
| 06/07/2023 |
4
| Drapkin Kimberlee C (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $5.2, valued at
$130k
|
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Porter Derrell (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $5.46, valued at
$273k
|
|
| 01/03/2023 |
4
| Zuga Matt (CFO and Chief Business Officer) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Exercised 50,000 options to buy
@ $1.19, valued at
$59.5k
|
|
| 09/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.59, valued at
$89.8k
|
|
| 06/17/2022 |
4
| Fountain Nathan B (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.59, valued at
$89.8k
|
|
| 06/17/2022 |
4
| Stoppel Laura (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.59, valued at
$89.8k
|
|
| 06/17/2022 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.59, valued at
$89.8k
|
|
| 06/17/2022 |
4
| Stalfort John A III (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.59, valued at
$89.8k
|
|
| 06/17/2022 |
4
| Sevigny Jeffrey (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.59, valued at
$89.8k
|
|
| 06/17/2022 |
4
| Drapkin Kimberlee C (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.59, valued at
$89.8k
|
|
| 04/04/2022 |
4
| Drapkin Kimberlee C (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.01, valued at
$200.5k
|
|
| 01/21/2022 |
4
| Zuga Matt (CFO and Chief Business Officer) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $5.19, valued at
$778.5k
|
|
| 01/21/2022 |
4
| Siemers Eric (Chief Medical Officer) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 90,000 options to buy
@ $5.19, valued at
$467.1k
|
|
| 01/21/2022 |
4
| OConnell Daniel Joseph (President and CEO) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 455,000 options to buy
@ $5.19, valued at
$2.4M
|
|
| 01/21/2022 |
4
| Barton Russell (COO) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 135,000 options to buy
@ $5.19, valued at
$700.7k
|
|
| 12/02/2021 |
4
| OConnell Daniel Joseph (President and CEO) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Exercised 1,118 options to buy
@ $4.47, valued at
$5k
|
|
| 07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
4
| OConnell Daniel Joseph (President and CEO) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Converted 123 shares
@ $0
Exercised (in-or-at-the-money) 35 shares
@ $4.47, valued at
$156.5
Paid exercise price by delivering 10 shares
@ $16, valued at
$160
Converted 123 preferred shares
@ $0
Exercised 35 warrants
@ $4.47, valued at
$156.5 |
|
| 07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|